S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Cellular Biomedicine Group Price Target & Analyst Ratings (NASDAQ:CBMG)

$14.76
+0.04 (+0.27 %)
(As of 10/22/2019 04:00 PM ET)
Today's Range
$14.70
Now: $14.76
$14.99
50-Day Range
$11.07
MA: $14.23
$15.28
52-Week Range
$10.98
Now: $14.76
$20.63
Volume11,719 shs
Average Volume39,537 shs
Market Capitalization$284.17 million
P/E RatioN/A
Dividend YieldN/A
Beta2.84

Analyst Ratings

Cellular Biomedicine Group (NASDAQ:CBMG) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Cellular Biomedicine Group in the last 12 months. Their average twelve-month price target is $24.00, suggesting that the stock has a possible upside of 62.60%. The high price target for CBMG is $27.00 and the low price target for CBMG is $19.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.67
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.00$27.50$30.33$32.00
Price Target Upside: 62.60% upside85.31% upside102.36% upside81.61% upside

Cellular Biomedicine Group (NASDAQ:CBMG) Consensus Price Target History

Cellular Biomedicine Group (NASDAQ:CBMG) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/17/2019BTIG ResearchInitiated CoverageBuy$19.00 ➝ $19.00Low
6/25/2019Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$27.00 ➝ $27.00High
2/6/2019Robert W. BairdInitiated CoverageOutperform ➝ Outperform$26.00Low
10/14/2018B. RileySet Price TargetBuy$38.00High
6/15/2018Maxim GroupReiterated RatingHoldLow
(Data available from 10/22/2017 forward)
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Featured Article: Equity Income

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel